Muscle Disease(MG vs Myopathy Ocular Perspective)

download Muscle Disease(MG vs Myopathy Ocular Perspective)

of 26

Transcript of Muscle Disease(MG vs Myopathy Ocular Perspective)

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    1/26

    Septemb er 2006. www.riogohchennai.ac. in 1 / 28

    Myasthenia and Myopathies -

    An Ocular Perspective.

    Dr. V. Natarajan.

    Additional Professor of NeurologyInstitute of NeurologyGovernment General Hospital and Madras Medical College

    Presentation atCME on Neuro-ophthalmic Disorders.

    at Regional Institute of Ophthalmology andGovernment Ophthalmic Hospital, Chennai.

    September 16, 2006.

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    2/26

    Septemb er 2006. www.riogohchennai.ac. in 2 / 28

    MYASTHENIA

    Ptosis or Diplopia

    Initial symptom in 2/3

    Fluctuation

    Spontaneous improvement

    Restricted weakness 10-40% Progression in 2 years

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    3/26

    Septemb er 2006. www.riogohchennai.ac. in 3 / 28

    Findings

    One or more ocular muscle

    Pupils spared

    Variable weakness, fatigability

    Shift of ptosis Pathognomonic

    Ocular quiver Superfast saccades

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    4/26

    Septemb er 2006. www.riogohchennai.ac. in 4 / 28

    Lid Twitch

    Lifting ptotic lid may cause the other lid to

    fall

    Covering of ptotic lid relieves contraction

    of opposite frontalis

    Ice pack test

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    5/26

    Septemb er 2006. www.riogohchennai.ac. in 5 / 28

    Investigations

    Anti Ach R antibody titre

    False positive is rare

    50% of OMG Antibody negative

    15% of GMG Antibody negative

    Anti Musk Ab 50% sero negative Ach R

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    6/26

    Septemb er 2006. www.riogohchennai.ac. in 6 / 28

    Edrophonium (Tensilon) Test

    Superseded

    Small risk of respiratory arrest, cardiac

    arrhythmias

    Resuscitation facilities

    Pre dose with Atropine

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    7/26Septemb er 2006. www.riogohchennai.ac. in 7 / 28

    Ideal dose cannot be predetermined

    escalating dose 2mg, 3mg, 5mg IV

    IM Neostigmine

    Positive in MND and OMN lesions

    Negative test does not exclude MG

    Edrophonium (Tensilon) Test

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    8/26Septemb er 2006. www.riogohchennai.ac. in 8 / 28

    Neurophysiologic Tests

    RNS

    Supra maximal 3 Hz decrement

    SF-EMG More sensitive

    2 muscle fibers in 1 unit

    Inter potential interval variability

    Jitter / Block

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    9/26Septemb er 2006. www.riogohchennai.ac. in 9 / 28

    Treatment

    Ach EI Symptom relief

    Steroids Individualized

    Thymectomy Debatable

    Young patients

    Recent onset Poor response to Ch EI

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    10/26Septemb er 2006. www.riogohchennai.ac. in 10 / 28

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    11/26Septemb er 2006. www.riogohchennai.ac. in 11 / 28

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    12/26Septemb er 2006. www.riogohchennai.ac. in 12 / 28

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    13/26Septemb er 2006. www.riogohchennai.ac. in 13 / 28

    OCULO PHARYNGEAL

    MUSCULAR DYSTROPHY

    Same age group as MG 5th & 6th decade

    EOM & Ptosis asymmetrical

    Swallowing difficulty

    Facial & limb weakness

    EMG & Muscle biopsy

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    14/26Septemb er 2006. www.riogohchennai.ac. in 14 / 28

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    15/26Septemb er 2006. www.riogohchennai.ac. in 15 / 28

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    16/26Septemb er 2006. www.riogohchennai.ac. in 16 / 28

    Myotonic Dystrophy

    Ptosis, no EOM involvement

    Facial appearance wasting

    Associated features Cardiac

    Cataract

    Endocrine & Testicular atrophy

    Myotonia on percussion

    EMG

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    17/26

    Septemb er 2006. www.riogohchennai.ac. in 17 / 28

    Mitochondrial myopathy

    Progressive external ophthalmoplegia with

    or without limb weakness

    RP, heart block, endocrinopathies Lactate, Pyruvate

    CSF proteins

    Muscle biopsy

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    18/26

    Septemb er 2006. www.riogohchennai.ac. in 18 / 28

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    19/26

    Septemb er 2006. www.riogohchennai.ac. in 19 / 28

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    20/26

    Septemb er 2006. www.riogohchennai.ac. in 20 / 28

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    21/26

    Septemb er 2006. www.riogohchennai.ac. in 21 / 28

    Congenital Myopathies

    Centro muscular or myotubular myopathy

    X linked recessive- infantile; AD- in later

    life

    Ptosis, EOM, facial and limb muscles

    EMG Spontaneous activity

    Muscle biopsy

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    22/26

    Septemb er 2006. www.riogohchennai.ac. in 22 / 28

    Tolosa Hunt Syndrome

    Inflammatory pathology in anterior

    cavernous sinus, SOF

    Usually painful

    EOM paresis, asymmetrical

    Steroid responsive

    Recurrent Associated V, II helpful

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    23/26

    Septemb er 2006. www.riogohchennai.ac. in 23 / 28

    Partial III Nerve

    Superior branch

    Ptosis, Superior rectus

    Pupil spared

    Idiopathic, viral, aneurysm of IC, PCom

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    24/26

    Septemb er 2006. www.riogohchennai.ac. in 24 / 28

    Congenital Myasthenic Syndromes (CMS)

    Heterogenous group

    Genetic defects affecting NMT

    Presynaptic, synaptic and post synaptic

    defects

    Muscle weakness Increases by exertion

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    25/26

    Septemb er 2006. www.riogohchennai.ac. in 25 / 28

    Early onset

    Opthalmoplegia, ptosis, bulbar

    Amyotrophy, tendinous retraction facial

    malformation

    Family history

  • 7/28/2019 Muscle Disease(MG vs Myopathy Ocular Perspective)

    26/26

    S t b 2006 i h h i i 26 / 28